Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind multicenter phase II trial of pirfenidone tablets in idiopathic pulmonary fibrosis
CTR20130709Phase 2Active
- Sponsor
- Chengdu Yaogong Pharmaceutical Biotechnology Research Institute
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pirfenidone in idiopathic pulmonary fibrosis (IPF), sponsored by Chengdu Yaogong Pharmaceutical Biotechnology Research Institute. Started Apr 2014; status: active.
02
Drugs
pirfenidone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on CTR20130709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130709.